The FDA greenlit multiple new drugs this month and issued some notable label expansions including for Eli Lilly’s Kisunla. Meanwhile, the regulator turned away a cell therapy for Duchenne muscular dystrophy and a gene therapy for the rare disease Sanfilippo syndrome.
FDA Issued Myeloma, Alzheimer’s Approvals in July but Rejected Two CGTs Read More »
Employed biopharma professionals are highly likely to look for new jobs in the next 12 months, although not quite as likely as their unemployed counterparts, according to a BioSpace LinkedIn poll. Three recruitment experts discuss the findings and what’s driving job searches.
Greener Pastures? 81% of Employed Biopharma Professionals Want New Jobs, BioSpace Finds Read More »
While Eli Lilly’s diabetes blockbuster was non-inferior to its older incretin therapy Trulicity in a highly anticipated Phase III cardiovascular outcomes trial, analysts had hoped for statistical significance in reducing major events such as cardiovascular death, heart attack and stroke.
Lilly’s Mounjaro ‘Good Enough’ in Cardio Trial, Will Seek Expanded Approval Read More »
The announced reduction of hundreds of staff came a day ahead of Moderna’s Q2 earnings report.
Moderna Slashes Global Workforce by 10% as $1.5B Cost Cuts Hit Home Read More »
Rumors of Biogen’s disagreements with Eisai have been greatly exaggerated, CEO Chris Viehbacher said during a second quarter earnings call. The partnered Alzheimer’s drug Leqembi saw sales climb 20% for the period.
Biogen’s Leqembi Push Getting Easier as CEO Eyes Early-Stage Pipeline Restock Read More »
Se ha conseguido un avance clave hacia la creación de vacunas más eficaces con ARN para proteger de infecciones a las plantas sin tener que modificar sus genes. El logro es obra de un equipo que incluye a científicos del Instituto de Biología Molecular y Celular …
Vía para lograr vacunas más eficaces para plantas sin modificar sus genes Read More »
Hoy en día en España, casi cualquiera puede percibir cómo la transición energética ya está llamando a las puertas de nuestros hogares. No se trata solo de una idea modernista, sino más bien de un cambio que puede sentirse en el bolsillo mes a mes. Cad …
Del gas al sol: cómo la energía solar se convierte en el motor económico de la vivienda Read More »
El micronutriente taurina es uno de los aminoácidos más abundantes en los animales, incluyendo al ser humano, y está reconocido por sus amplias funciones biológicas y sus posibles beneficios para la salud. Algunos estudios recientes han demostrado que los niveles de tauri …
¿Es la taurina un biomarcador fiable del envejecimiento? Read More »
More than 60 companies, including Amazon, Google, UnitedHealth and Epic, have pledged to participate in the initiative, which the CMS said would “deliver results” early next year.
Trump administration launches health data sharing initiative Read More »
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of patient data driving AI tasks with Louise Molloy, associate director medical information and pharmacovigilance.
We Don’t Own Patient Data–We’re Just Babysitting It Read More »
